Longitudinal studies are also warranted to track changes in serotonin, SERT protein, and mRNA expression over time, especially in response to standard OSA treatments like continuous positive airway pressure (CPAP) therapy. The gene discussed is SLC6A4; the disease is obstructive sleep apnea syndrome.